Related Experiment Video
Updated: Jun 7, 2026
12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Prosthetic valve selection for middle-aged patients with aortic stenosis
Joanna Chikwe1, Farzan Filsoufi, Alain F Carpentier
1Department of Cardiothoracic Surgery, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029-6574, USA.
Nature Reviews. Cardiology
|November 4, 2010
Summary
For middle-aged patients with aortic stenosis, mechanical valves carry lifelong bleeding risks, while bioprosthetic valves face degeneration. Patient choice is key, with biological valves often preferred.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Aortic stenosis management in middle-aged adults involves complex prosthesis selection.
- Both mechanical and bioprosthetic valves have significant drawbacks impacting long-term outcomes.
Purpose of the Study:
- To compare the long-term survival and complication risks of different aortic valve prostheses in middle-aged patients.
- To inform clinical decision-making and patient choice regarding aortic valve replacement options.
Main Methods:
- Comparative analysis of existing data on mechanical valves, bioprosthetic valves, and the Ross procedure.
- Evaluation of survival rates, hemorrhagic/embolic event risks, and structural valve degeneration.
Main Results:
- No significant survival difference between mechanical and bioprosthetic valves at 10-15 years.
- Mechanical valves have a 2-4% annual risk of major bleeding/embolism; bioprosthetic valves have ~1% annual risk.
- Bioprosthetic valves show increasing degeneration post-10 years, often necessitating reoperation with similar mortality to primary surgery.
Conclusions:
- Biological valves are increasingly favored over mechanical options for middle-aged patients due to lower bleeding risks.
- Informed patient choice, considering lifelong risks and reoperation likelihood, is paramount in prosthesis selection.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...